Dr Reddys Laboratories (RDY) Operating Expenses (2012 - 2026)

Dr Reddys Laboratories' Operating Expenses history runs 15 years deep, the most recent figure standing at $335.0 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 2.04% year-over-year to $335.0 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 23.52% YoY), while the FY2026 annual figure was $1.4 billion, down 2.74% from the prior year.
• Operating Expenses was $335.0 million for Q1 2026 at Dr Reddys Laboratories, down from $365.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $365.7 million in Q4 2025 to a low of $8.0 million in Q3 2025.
• Historically, Operating Expenses has averaged $287.8 million across 5 years, with a median of $299.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses surged 49.13% in 2023, then plunged 97.79% in 2025.
• A 5-year view of Operating Expenses shows it stood at $284.5 million in 2022, then gained by 5.27% to $299.5 million in 2023, then increased by 19.96% to $359.2 million in 2024, then climbed by 1.8% to $365.7 million in 2025, then slipped by 8.39% to $335.0 million in 2026.
• The last three Operating Expenses figures came in at $335.0 million (Q1 2026), $365.7 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.